Expression of clock genes in patients with colorectal cancer

International Journal of Biological Markers

Volumn 28, Issue 3, 2013, Pages 280-285

  Karantanos, Theodoros ^a   Theodoropoulos, George ^a   Gazouli, Maria ^a   Vaiopoulou, Anna ^a   Karantanou, Christina ^a   Lymberi, Maria ^a   Pektasides, Dimitrios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Circadian rhythm; Clock genes; Colorectal cancer; Gene expression

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PER1 PROTEIN; PER2 PROTEIN; PROTEIN BMAL1; TRANSCRIPTION FACTOR CLOCK; CIRCADIAN RHYTHM SIGNALING PROTEIN;

APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CELL CYCLE REGULATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLONOSCOPY; COLORECTAL CANCER; DNA DAMAGE; DNA REPAIR; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; BIOLOGICAL RHYTHM; BIOSYNTHESIS; CIRCADIAN RHYTHM; COLORECTAL TUMOR; GENETICS; METABOLISM; PATHOLOGY;

BIOLOGICAL CLOCKS; CIRCADIAN RHYTHM; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; PERIOD CIRCADIAN PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84885896706     PISSN: 03936155     EISSN: 17246008     Source Type: Journal    
DOI: 10.5301/JBM.5000033     Document Type: Article

References (23)

1. Borgs L, Beukelaers P, Vandenbosch R, Belachew S, Nguyen L, Malgrange B. Cell "circadian" cycle: new role for mammalian core clock genes. Cell Cycle 2009; 8: 832-837.
2. Herzog ED, Takahashi JS, Block GD. Clock controls circadian period in isolated suprachiasmatic nucleus neurons. Nat Neurosci 1998; 1: 708-713.
3. Sakamoto K, Nagase T, Fukui H, et al. Multitissue circadian expression of rat period homolog (rPer2) mRNA is governed by the mammalian circadian clock, the suprachiasmatic nucleus in the brain. J Biol Chem 1998; 273: 27039-27042.
4. Ko CH, Takahashi JS. Molecular components of the mammalian circadian clock. Hum Mol Genet 2006; 15: R271-R277.
5. Delaunay F, Laudet V. Circadian clock and microarrays: mammalian genome gets rhythm. Trends Genet 2002; 18: 595-7.
6. Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G. The molecular clock mediates leptin-regulated bone formation. Cell 2005; 122: 803-815.
7. Gréchez-Cassiau A, Rayet B, Guillaumond F, Teboul M, Delaunay F. The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. J Biol Chem 2008; 283: 4535-4542.
8. Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler HP. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell 2006; 22: 375-382.
9. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 2003; 3: 350-361.
10. Alhopuro P, Björklund M, Sammalkorpi H, et al. Mutations in the circadian gene CLOCK in colorectal cancer. Mol Cancer Res 2010; 8: 952-960.
11. Zeng ZL, Wu MW, Sun J, et al. Effects of the biological clock gene Bmal1 on tumour growth and anti-cancer drug activity. J Biochem 2010; 148: 319-326.
12. Mazzoccoli G, Panza A, Valvano MR, et al. Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients. Chronobiol Int 2011; 28: 841-51.
13. Wang Y, Hua L, Lu C, Chen Z. Expression of circadian clock gene human Period2 (hPer2) in human colorectal carcinoma. World J Surg Oncol 2011; 9: 166.
14. Oshima T, Takenoshita S, Akaike M, et al. Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer. Oncol Rep 2011; 25: 1439-1446.
15. Yang MY, Chang JG, Lin PM, et al. Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3. Cancer Sci 2006; 97: 1298-307.
16. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science 2003; 302: 255-259.
17. Lin F, Chen Y, Li X, Zhao Q, Tan Z. Over-expression of circadian clock gene Bmal1 affects proliferation and the canonical Wnt pathway in NIH-3T3 cells. Cell Biochem Funct 2013; 31: 166-172.
18. Elshazley M, Sato M, Hase T, et al. The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma. Int J Cancer 2012; 131: 2820-2831.
19. Taniguchi H, Fernández AF, Setién F, et al. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies. Cancer Res 2009; 69: 8447-8454.
20. Koyanagi S, Kuramoto Y, Nakagawa H, et al. A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res 2003; 63: 7277-7283.
21. Krugluger W, Brandstaetter A, Kállay E, et al. Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors. Cancer Res 2007; 67: 791779-22.
22. Sotak M, Polidarova L, Ergang P, Sumova A, Pacha J. An association between clock genes and clock-controlled cell cycle genes in murine colorectal tumors. Int J Cancer 2013; 132: 1032-1041.
23. Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL. Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. Neoplasia 2007; 9: 797-800.